Comparative profiling of immune genes improves the prognoses of lower grade gliomas
Objective: Lower grade gliomas (LGGs), classified as World Health Organization (WHO) grade II and grade III gliomas, comprise a heterogeneous group with a median survival time ranging from 4–13 years. Accurate prediction of the survival times of LGGs remains a major challenge in clinical practice. M...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
China Anti-Cancer Association
2022-04-01
|
| Reeks: | Cancer Biology & Medicine |
| Onderwerpen: | |
| Online toegang: | https://www.cancerbiomed.org/content/19/4/533 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|